These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30204260)

  • 1. Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.
    Tiwari S; Lapierre J; Ojha CR; Martins K; Parira T; Dutta RK; Caobi A; Garbinski L; Ceyhan Y; Esteban-Lopez M; El-Hage N
    J Neurosci Res; 2018 Dec; 96(12):1831-1846. PubMed ID: 30204260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: risk factors and their interactions.
    Disanto G; Morahan JM; Ramagopalan SV
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):545-55. PubMed ID: 22583442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: immune mechanism and update on current therapies.
    Bansil S; Cook SD; Rohowsky-Kochan C
    Ann Neurol; 1995 May; 37 Suppl 1():S87-101. PubMed ID: 8968220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.
    Correale J; Gaitán MI
    Acta Neurol Scand; 2015; 132(199):46-55. PubMed ID: 26046559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
    Peterson LK; Fujinami RS
    J Neuroimmunol; 2007 Mar; 184(1-2):37-44. PubMed ID: 17196667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
    Martin R; Sospedra M; Rosito M; Engelhardt B
    Eur J Immunol; 2016 Sep; 46(9):2078-90. PubMed ID: 27467894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
    Hojati Z
    Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
    Wingerchuk DM
    Mt Sinai J Med; 2011; 78(2):221-30. PubMed ID: 21425266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the immunopathogenesis of multiple sclerosis.
    Yadav SK; Mindur JE; Ito K; Dhib-Jalbut S
    Curr Opin Neurol; 2015 Jun; 28(3):206-19. PubMed ID: 25887768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of LIF in multiple sclerosis.
    Slaets H; Hendriks JJ; Stinissen P; Kilpatrick TJ; Hellings N
    Trends Mol Med; 2010 Nov; 16(11):493-500. PubMed ID: 20870461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells in multiple sclerosis: A review.
    Mimpen M; Smolders J; Hupperts R; Damoiseaux J
    Immunol Lett; 2020 Jun; 222():1-11. PubMed ID: 32113900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis is linked to MAPK
    Ten Bosch GJA; Bolk J; 't Hart BA; Laman JD
    J Mol Med (Berl); 2021 Aug; 99(8):1033-1042. PubMed ID: 33948692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral induced demyelination.
    Stohlman SA; Hinton DR
    Brain Pathol; 2001 Jan; 11(1):92-106. PubMed ID: 11145206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MULTIPLE SCLEROSIS - RISK FACTORS.
    Adamczyk-Sowa M; Gębka-Kępińska B; Kępiński M
    Wiad Lek; 2020; 73(12 cz 1):2677-2682. PubMed ID: 33577489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis Risk Factors and Pathogenesis.
    Nourbakhsh B; Mowry EM
    Continuum (Minneap Minn); 2019 Jun; 25(3):596-610. PubMed ID: 31162307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viruses and multiple sclerosis.
    Cermelli C; Jacobson S
    Viral Immunol; 2000; 13(3):255-67. PubMed ID: 11016591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.